跳至主要内容
临床试验/NCT03308188
NCT03308188已完成不适用

EMPOWER: Evaluating the Ability to Reduce Morphine Equivalent Dose for Chronic Pain Patients Receiving Opioid-therapy Through a Web-based E-Health Self-management Program: a Randomized Multi-site Clinical Trial in Primary Care

University of Cincinnati2 个研究点 分布在 1 个国家目标入组 402 人开始时间: 2018年2月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
402
试验地点
2
主要终点
Decrease in Morphine Equivalent Dose (MED)

研究概览

简要总结

This is a 10-month internet-based randomized controlled trial to evaluate whether an online chronic pain management program ("E-Health") can assist with reduced opioid reliance in chronic pain patients. About half of the eligible participants will receive access to the E-Health program in addition to their standard chronic pain treatment; the other half will just continue receiving their standard chronic pain treatment.

详细描述

This study will determine whether an innovative, accessible E-health intervention can assist with reduced opioid reliance in chronic pain patients, which can, ultimately, reduce risks of unintended opioid overdose and death. Importantly, the study will contribute to a better understanding of the mechanisms contributing to opioid use reduction while managing pain. The findings may assist in developing treatment options for a population at risk for opioid adverse effects.

Potential participants will be identified through electronic health record (EHR) queries at participating sites. Participants will be assessed at baseline, at the end of the 4-month treatment period, and at 6 months following end-of-treatment through an electronic data capture system accessed by the participants. Other outcome data will be obtained from the participant's EHR data.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Be 25-80 years of age
  • •Be able to understand the study, and having understood, provide informed consent in English
  • •Have a daily average prescribed MED ≥ 20 mg over a recent three-month period
  • •Have a chronic pain-related diagnosis
  • •Self-report current use of opioid medication(s) to treat pain
  • •Have a Brief Pain Inventory Pain Intensity score ≥3
  • •Have internet access and a working email account

排除标准

  • •Be anyone who, in the judgment of study staff, would be unlikely to complete the study (e.g., planning to change to a different primary care clinic, have a terminal illness, etc.)
  • •Be unwilling/unable to complete the WebNeuro assessments
  • •Be pregnant
  • •Be a prisoner

研究组 & 干预措施

Treatment As Usual

No Intervention

Participants randomized to Treatment As Usual will receive treatment for chronic pain as typically provided by their clinician -- they will receive no extra treatment from the study.

E-Health+

Experimental

Participants randomized to the E-health+ arm will receive treatment as typically provided by their clinician plus a 4-month subscription to the E-health program, which is an internet based chronic pain program.

干预措施: E-health program (Behavioral)

结局指标

主要结局

Decrease in Morphine Equivalent Dose (MED)

时间窗: Baseline and 10 months

Whether (yes/no) there was a ≥15% decrease in MED, between baseline and 10-month post-randomization follow-up.

次要结局

  • Pain Intensity(Baseline and 10 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

T. John Winhusen, PhD

Professor; Vice Chair and Division Director of Addiction Sciences

University of Cincinnati

研究点 (2)

Loading locations...

相似试验